Conclusions
In our review of 604 patients with cardiogenic shock undergoing conventional cardiac surgery, we describe high rates of early morbidity and mortality. However, despite this, 62% of patients survive to 5 years and most do not require heart failure readmission or advanced heart failure surgical therapy during follow-up. These data are therefore supportive of conventional cardiac surgery in appropriately selected patients presenting in cardiogenic shock.
Acknowledgements
None